Side-by-side comparison of AI visibility scores, market position, and capabilities
NYSE-listed (EB) global self-service event ticketing platform with 300M+ tickets/year in 180+ countries; competing with Ticketmaster and Dice for independent creator and organizer platform at $343M revenue.
Eventbrite is a San Francisco-based global event management and ticketing platform enabling independent creators, nonprofits, and businesses to sell tickets and registrations for events ranging from yoga classes and comedy shows to conferences and music festivals. Founded in 2006 by Julia Hartz, Kevin Hartz, and Renaud Visage and listed on NYSE (NYSE: EB), Eventbrite generated $343 million in revenue in fiscal year 2024 with presence in 180+ countries, 300+ million tickets processed annually, and a creator-focused self-service model serving the long tail of events that traditional ticketing companies (Ticketmaster, AXS) don't serve.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.